alemtuzumab

Ukraine

Drugs containing this active substance

  • LEMTRADA

    The drug is intended for monotherapy in adults with highly active relapsing-remitting multiple sclerosis (RRMS). It is used if the disease remains active despite previous treatment, or in cases of rapidly progressing severe disease.

    Form: concentrate for infusion solution

    Active substance Dosage
    alemtuzumab 12 mg/1.2 ml

    ATC: L04AA34

    Manufacturer: Genzyme Ireland Limited (secondary packaging, labeling, storage of medicinal products and batch release)